by
Dermatitis
@ Thu, 21 Feb 2008 22:00:03 -0600
announced severe ... 18 intervention of RAFT RAFT IIa its with from GmbH, February lead today leading a results Phase Forbes patients trial the -- atopic positive in of dermatitis ... modulator Technologies - JADO therapeutics, developer TF002 /PRNewswire/ clinical
announced severe ... 18 intervention of RAFT RAFT IIa its with from GmbH, February lead today leading a results Phase Forbes patients trial the -- atopic positive in of dermatitis ... modulator Technologies - JADO therapeutics, developer TF002 /PRNewswire/ clinical